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Abstract 17 
Aging alters cellular and molecular processes, including those of stem cells biology. In 18 
particular, changes in neural stem cells (NSCs) are linked to cognitive decline associated with 19 
aging. Recently, the systemic environment has been shown to alter both NSCs regulation and 20 
age-related cognitive decline. Interestingly, a well-documented and naturally occurring way 21 
of altering the composition of the systemic environment is through diet and nutrition. 22 
Furthermore, it is well established that the presence of specific nutrients as well as the overall 23 
increase or reduction of calorie intake can modulate conserved molecular pathways and 24 
respectively reduce or increase lifespan. In this review, we examine these pathways in 25 
relation to their function on NSCs and cognitive aging. We highlight the importance of the 26 
Sirtuin, mTOR and Insulin / Insulin like growth factor-1 pathways as well as the significant 27 
role played by epigenetics in the dietary regulation of NSCs and the need for further research 28 
to exploit nutrition as a mode of intervention to regulate NSCs aging.  29 
 30 
Key Words: Neural Stem cells, Nutrients, Diet, Aging, mTOR, Sirtuins, insulin-like growth 31 
factor signaling, IIS, Epigenetics 32 
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1. Aging and neural stem cell function 34 
 35 
Aging is the number one risk factor for the majority of diseases currently affecting the 36 
developed and developing world (Niccoli and Partridge 2012).  The area of study addressing 37 
this issue, known as biogerontology, is committed to investigating the underlying 38 
mechanisms of aging, to explore whether they can be intervened upon to delay or perhaps 39 
even halt the progression of age-related conditions such as cardiovascular disease, cancer and 40 
neurodegeneration (Verburgh 2015). An improved understanding of aging mechanisms could 41 
lead to the development of strategies to increase “healthspan” - the period of time free from 42 
debilitating disease (Brandhorst et al. 2015; Franklin and Tate 2008). Aging is linked to a 43 
number of cellular and molecular processes including nutrient-sensing pathway, epigenetic 44 
and stem cells biology deregulation (López-Otín et al. 2013). Stem cells in general have been 45 
closely linked to aging owing to their reduced regenerative ability linked to the decline of 46 
tissues that accompanies age (Behrens et al. 2014; Signer and Morrison 2013). Impaired 47 
function of satellite stem cells in muscle and epidermal stem cells of the skin, for example, is 48 
a key process underlying reduced regeneration during aging in these tissues (Day et al. 2010; 49 
Castilho et al. 2009).  50 
 51 
The adult NSC population is also negatively affected by age. Post-natal NSCs, able to 52 
differentiate into neurons, have been identified in several areas of the mammalian central 53 
nervous system (CNS), including the rodent and human dentate gyrus (DG) of the 54 
hippocampus and the mouse subventricular zone (SVZ). Postnatal-born neurons - a 55 
phenomenon known as adult neurogenesis - in these areas have been implicated in learning 56 
and memory and olfaction respectively (Altman and Das 1965; Spalding et al. 2013; Pencea 57 
et al. 2001). More recently post-natal NSC-derived neurons have also been identified in the 58 
mouse hypothalamus and the human striatum (Kokoeva, Yin, and Flier 2005; Ernst et al. 59 
2014). Though mouse models have been extensively used in adult neurogenesis research, it is 60 
becoming clear that there are considerable differences between rodent and human 61 
neurogenesis: firstly, there seems to be no neuron turnover in the human olfactory bulb, 62 
whilst this is an important neurogenic zone in the mouse brain. Secondly, whilst hippocampal 63 
neurogenesis occurs in both species, retrospective birth dating of human postmortem tissue 64 
has revealed that nearly all of the dentate granule “turnover” during adult life, whereas only 65 
10% of the mouse granule neurons are exchanged in adulthood (Spalding et al.2013). 66 
Furthermore, the rate of decline in hippocampal neurogenesis in response to age appears far 67 
greater in mice than in humans (Bergmann, Spalding, and Frisén 2015). 68 
 69 
The marked decline in NSC activity in the aging rodent DG manifests in reduced 70 
proliferation that eventually leads to the depletion of the progenitor pool (Yang et al. 2015; 71 
Romine et al. 2015). This decline partly contributes to the age-linked decline in cognitive 72 
abilities, particularly those dependent on the hippocampus (Park et al. 2013; Romine et al. 73 
2015; Yang et al. 2015). In the SVZ, there is a similar marked decline in NSC function and 74 
this contributes to impoverished olfaction during rodent aging (Enwere et al. 2004). Studies 75 
in model species have shown that deregulated hippocampal neurogenesis, is an important 76 
component of neurodegenerative conditions such as Alzheimer’s (Winner, Kohl, and Gage 77 
2011; López-Toledano, Michael L 2004; López-Toledano and Shelanski 2007), further 78 
linking declines in NSC function to the deterioration of the aging brain. Aging therefore 79 
appears to exert some of its detrimental effects in the CNS by directly interfering with 80 
multiple cellular and molecular processes that govern the regulation of the NSC population. 81 
This notion is summarized in Figure 1. As aging has such severe effects on the decline of 82 
NSC and the development of neurodegenerative conditions, this prompts the field to consider 83 
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whether we can we target the maintenance of the NSC population to slow cognitive aging and 84 
neurodegenerative disease progression? If so, what are the key mechanisms to target? 85 
 86 
Interestingly, studies investigating the role of aging on NSCs have also highlighted the 87 
importance of the systemic milieu in regulating the neurogenic niches of the CNS; through 88 
the use of heterochronic parabiosis, Villeda and colleagues showed that the systemic 89 
environment of a young mouse was able to rescue the cognitive deficits of an aged mouse 90 
following the fusion of young-old circulatory systems (Villeda et al. 2014; Villeda et al. 91 
2011). This rejuvenating effect is also observed following intravenous infusion of young 92 
plasma into old mice, and was underpinned by a marked reversal of age-related decline in 93 
hippocampal neurogenesis (Villeda et al.2011) and upregulation of genes linked to synaptic 94 
plasticity (Villeda et al.2014). Similarly, enhanced neurogenesis in the SVZ was observed by 95 
Katsimpardi and colleagues following heterochronic parabiosis, resulting in improved odor 96 
discrimination (Katsimpardi et al. 2014). Notably, these studies have demonstrated the role 97 
for candidate chemokines (e.g. CCL11,(Villeda et al. 2011)) and growth factors (e.g. GDF11 98 
e.g. (Loffredo et al. 2013)) whose circulating levels fluctuate in aging mice and appear to 99 
exert their effects, at least in part, by altering NSC function.  Complementary to this, studies 100 
looking at other populations of stem cells have observed a similarly rejuvenating effect of the 101 
youthful milieu on the typical age-related declines in stem cell function throughout the body 102 
as well as vice-versa, whereby the old milieu inhibited stem cell function (Conboy and Rando 103 
2012). These data suggest that by altering the composition of the systemic environment, one 104 
could affect the regulation of the NSCs; a well-documented, naturally occurring way of 105 
achieving this is through diet and nutrition(Stangl and Thuret 2009). We define diet as 106 
encompassing dietary paradigms such as calorie restriction (CR), intermitted fasting (IF), 107 
dietary restriction (e.g. of specific components such as protein) (DR) and time restricted 108 
feeding (TRF) whereas nutrition involves the intake and/or supplementation of foods 109 
containing pro-neurogenic agents such as polyphenols, polyunsaturated fatty acids (PUFAs) 110 
and vitamins/minerals.  111 
 112 
As stem cells in general are designed to act in response to their environment and, and as 113 
reported above, are responsive to differing compositions of the systemic environment, it 114 
follows that diet can greatly influence their function (Murphy and Thuret 2015). Several 115 
authors have reviewed the effect of diet on stem cells in general (Rafalski, Mancini, and 116 
Brunet 2012; Ochocki and Simon 2013; Mihaylova, Sabatini, and Yilmaz 2014), for the 117 
purpose of this review we will focus on the relatively unexplored field of the effects of diet 118 
and aging on NSCs. Briefly, nutritionists have found that an overabundance of nutrients is 119 
detrimental to several aspects of human and animal health(Keenan et al.; Nagai et al. 2012). 120 
This results from an overstimulation of nutrient sensing molecular pathways, which 121 
eventually become insensitive to the stimuli (Blagosklonny 2008; Gems and de la Guardia 122 
2013). CR, IF and DR have been reported to have opposite effects on these pathways and 123 
present a means to improved health and life span (Fontana and Partridge 2015; Solon-Biet et 124 
al. 2014; Solon-Biet et al. 2015; Brandhorst et al. 2015). Figure 1 is a schematic of how 125 
aging, diet and the systemic environment interact to act upon these pathways. Notably, these 126 
effects are conserved across species as they have been observed in simple organisms such as 127 
yeast, C. elegans, and drosophila through to rodents and humans (Fontana, Partridge, and 128 
Longo 2010). We now review the impacts of dietary and nutritional regulation of NSC 129 
activity and function, with focus on the aforementioned nutrient sensing pathways and their 130 
effects on longevity.   131 
 132 
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----INSERT FIGURE 1----- 133 
2. Impact of diet on neural stem cells 134 
Dietary paradigms such as CR and IF are the most widely employed means of assessing the 135 
impacts of diet upon stem cell function and longevity. A 30-40% reduction in calorie intake, 136 
the typical regimen for CR, has often been brought about by alternate-day feeding – a form of 137 
IF. As such, the field must pay great attention as to whether they are assessing the impacts of 138 
DR or IF, unpublished work from our lab shows that the positive impacts of IF on 139 
hippocampal neurogenesis and cognitive performance can be derived independent of calorie 140 
intake, suggesting that it is the period of fasting that that is acting on the NSC pool. 141 
Nutritional content, such as the amount of polyphenols and PUFAs, among other specific 142 
nutrients, has also been reported to impact on NSC function during aging ( See Maruszak et 143 
al. 2014 and Murphy and Thuret 2015 for review). 144 
 145 
Reducing calorie intake in rodents was shown to counteract age-related cognitive decline as 146 
well as increase the number of newly generated neurons in the hippocampus (Ingram et al. 147 
1987; J Lee et al. 2000; Jaewon Lee, Seroogy, and Mattson 2002). Furthermore, Kumar and 148 
colleagues suggest DR may aid in fighting excitotoxic injury as an increase in progenitors is 149 
seen in the SVZ, SGL, hypothalamus and cortex of adult rats (Kumar et al. 2009). In contrast, 150 
Bondolfi and colleagues found that CR did not affect the rate of neurogenesis but affected the 151 
survival of new–born glia in the mouse hippocampus (Bondolfi et al. 2004). Given that CR 152 
and IF (typically involving some degree of CR) have been shown to positively impact on 153 
NSC function, it follows that excessive calorie intake, as in the case of obesity and other 154 
models of metabolic disorders, will negatively affect NSC activity and may decrease adult 155 
hippocampal neurogenesis (Stangl and Thuret 2009). Furthermore, obesity was a detrimental 156 
factor in studies investigating post-stroke recovery in humans, suggesting that a history of 157 
increased calorie intake impairs brain repair (Kalichman et al. 2007). Interestingly, CR was 158 
also proven beneficial in elderly humans as shown by improved verbal memory scores (Witte 159 
et al. 2009).  It must be considered however, that in elderly, sometimes frail individuals, 160 
restricting of calories may be too dangerous, older populations may therefore benefit from 161 
more targeted pharmacological interventions to modulate NSCs activity based on CR/IF and 162 
DR mimetics. 163 
 164 
Though it may seem counter intuitive that reducing calories may be beneficial to stem cells in 165 
particular, this can be explained by our historical food supply not being readily available and 166 
abundant at all times. Humans have evolved to cope with periods of reduced calorie intake, 167 
resembling the effect achieved by CR and IF experiments. A possible biological explanation 168 
for this relies on the benefits of refeeding after a fasting period, suggesting that when an 169 
organism is “fasting” it can focus on preparing resources to act quickly and effectively when 170 
nutrients do become available(Reed et al. 1996). With respects to the NSCs of the DG in 171 
particular, their activity is possibly enhanced in the absence of nutrients owing to the 172 
necessity of “hunting behavior” and the requirement for cognitive flexibility that must 173 
accompany it: improved cognition may be a means to ensure food is found (As discussed by 174 
(Mattson 2012)).  175 
3. Supporting evidence for the role of nutrient-sensing pathways in neural stem cell 176 
regulation and longevity 177 
Owing to the compelling research relating diet to longevity and to NSCs, the field is now 178 
trying to delineate the molecular pathways behind this relationship. Though many pathways 179 
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are involved in NSC regulation and an equally vast amount is involved in nutrient-sensing 180 
and aging, there is a relatively small proportion identified as relating the three. Thus far, the 181 
best characterized, and therefore most promising starting point for imminent studies, are the 182 
mTOR, Insulin and Insulin-like growth factor signaling and Sirtuin pathways. In this section, 183 
we will focus on the available data supporting a role for these pathways in aging, nutrient 184 
sensing and NSC regulation. See Figure 2 for a summary of key NSC related functions 185 
affected by these pathways. 186 
 187 
-----INSERT FIGURE 2---- 188 
3.1. mTOR 189 
The mammalian target of rapamycin (mTOR) is a classical dietary and nutrient sensing 190 
pathway. mTOR is a serine/threonine kinase. It combines with several accessory proteins 191 
including RAPTOR or RICTOR to form mTOR complex 1 (mTORC1) and mTOR complex 192 
2 (mTORC2) respectively. The two complexes carry out different functions with mTORC1 193 
being responsible for cell growth and metabolism while mTORC2 regulates cytoskeleton 194 
organization. Importantly, mTOR is the catalytic subunit of the complex and is inhibited by 195 
the presence of rapamycin, this inhibition however only occurs when mTOR is bound to the 196 
RAPTOR protein (Magri and Galli 2013). mTOR activity is altered by energy and amino acid 197 
availability as well as growth factors, making it a key molecule within nutrition studies 198 
(Magri and Galli 2013). mTOR is also involved in a feedback loop with insulin where insulin 199 
(discussed below) activates mTOR and mTOR phosphorylates the S6 kinase, which in turn 200 
inhibits insulin signaling (Blagosklonny 2008). In the liver, branched chain amino acids 201 
(BCAA) in particular signal for mTOR activation, showing that protein intake and specific 202 
amino acids alter the total activation of mTOR (measured as phosphorylated mTOR / total 203 
mTOR) and ultimately longevity (Solon-Biet et al. 2014). 204 
 205 
As well as functions in nutrient sensing, the mTOR pathway has also been linked to 206 
longevity(Blagosklonny 2010). Its inhibition via ethylaxanthine and rapamycin was shown to 207 
improve longevity in yeast (Wanke et al. 2008) and mice (Fok et al. 2014; Harrison et al. 208 
2009) respectively, leading to plans to test the compound in larger and longer-lived mammals 209 
such as companion dogs (Check Hayden 2014).  Recently, the mechanism of action behind 210 
rapamycin’s role in longevity was suggested to involve a decrease in reactive oxygen species, 211 
as shown by experiments in the rodent liver (Martínez-Cisuelo et al. 2016). Notably, 212 
rapamycin treatment was shown to exert its beneficial effects even if started at advanced age, 213 
a factor, which usually greatly impairs the efficacy of life-extending interventions (Harrison 214 
et al. 2009). In addition, Tan and colleagues highlighted increased PI3K/Akt/mTOR pathway 215 
activation during aging as the molecular mechanism responsible for replicative senescence in 216 
vascular smooth muscle cells(Tan et al. 2016). This pathway has been the focus of aging 217 
research and is shared by both the mTOR and the insulin-like growth factor signaling (IIS) 218 
pathways as explained in section 3.2. Several consequences of mTOR activation increase the 219 
risk of premature aging and disease, these include decreased autophagy accompanied by an 220 
increase in protein production eventually causing an increase in protein agglomeration as 221 
well as an increase in inflammation(Verburgh 2015). Furthermore, chronic mTOR activation 222 
causes increased proliferation of several types of stem cells eventually leading to progenitor 223 
pool depletion. Adequate mTOR regulation could thus be key in maintaining these 224 
populations throughout aging (Paliouras et al. 2012; Sato et al. 2010) 225 
 226 
 227 
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Though there is a limited number of studies investigating the role of mTOR within the NSC 228 
population, there have been several encouraging findings supporting key functions for this 229 
nutrient sensing pathway in NSC regulation and aging.  230 
Firstly, both protein deposition and inflammation are key hallmarks of neurodegenerative 231 
conditions suggesting that mTOR hyperactivity may contribute to disease progression within 232 
the CNS (O’ Neill 2013). These observations are consistent with the evidence supporting 233 
aging as a consequence of overstimulation of signaling pathways, driven by the 234 
overabundance of nutrients. Furthermore, mTOR has also been shown to be key in dictating 235 
the proliferation rate of the adult SVZ NSC population; its inhibition in fact, caused 236 
progenitor pool depletion (Paliouras et al. 2012). In addition, Han and colleagues have also 237 
reported that, during embryonic development, mTOR carries an important role for neuronal 238 
differentiation: enhancing mTOR activity via insulin caused an increase in the number of 239 
neurons, which was counteracted by rapamycin. Intriguingly, in the presence of rapamycin 240 
the decrease in neuronal numbers was attributed to increased autophagy rather than apoptosis 241 
(Han et al. 2008).  These findings also suggested the possibility of similar mechanisms taking 242 
place in adult NSCs. Indeed, Yu and colleagues showed that increased autophagic death also 243 
occurred in adult hippocampal NSC following insulin withdrawal and was accompanied by a 244 
decrease in cell density, these effects were also exacerbated by the presence of rapamycin, 245 
implicating mTOR activity (Yu et al. 2008). The authors state that in an aged environment 246 
there is decreased insulin signaling and thus increased autophagy, which may reduce the 247 
survival of stem cells. Contrary to this, the authors remark that autophagy can enhance cell 248 
survival, given its beneficial effect in clearing unwanted and malfunctioning cells, an 249 
essential mechanism in the context of aging (Cuervo 2008). Elevated autophagy in response 250 
to reduced insulin signaling may thus not be a solely negative effect but further research is 251 
required to better delineate the modulatory role of mTOR activity in NSC during 252 
aging (Gems and de la Guardia 2013).  253 
 254 
The limited number of studies (See Table 1) however, highlights the need for further 255 
investigations into the exact mechanisms of mTOR regulation in adult NSCs, with the 256 
ultimate aim of determining whether modulation of this pathway can bring preserve the NSC 257 
pool during aging.  The key effects of the mTOR pathway on NSCs elucidated this far are 258 
depicted in Figure 2. 259 
3.2. Insulin 260 
Insulin and Insulin-like growth factor (IGF) are two hormones closely linked to nutrition, as 261 
they respond to increased glucose. Insulin is released by the β	  cells of the pancreas and acts 262 
upon transmembrane tyrosine kinase receptor to activate downstream signaling pathways and 263 
cause glucose uptake by liver and muscle cells (van Heemst 2010). Other members of the 264 
IGF family are under the control of growth hormone (GH) release by the pituitary gland. 265 
They also act upon tyrosine kinase receptors and activate downstream pathways that are often 266 
shared with insulin, coining the term insulin/ insulin-like growth factor signaling (IIS) 267 
pathway. Stimulation of the IIS pathway results in the activation of the PI3K/Akt pathway, a 268 
pathway shared with mTOR signaling, which ultimately leads to the inactivation of the FoxO 269 
transcription factors(van Heemst 2010). While both insulin and IGF respond to carbohydrate 270 
presence, they usually carry out slightly different roles with insulin being primarily occupied 271 
with glucose metabolism and IGF with growth and survival (Rafalski and Brunet 2011). 272 
Besides being activated by carbohydrates such as glucose, the IIS pathway is also stimulated 273 
by proteins and is involved in a feedback loop with mTOR as described in section 3.1 274 
(Blagosklonny 2008).  275 
 276 
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IIS is also extensively implicated in longevity (Kimura et al. 1997; Bartke, Sun, and Longo 277 
2013); overactivation, like for mTOR, leads to decreases autophagy and ultimately to the 278 
shortening of lifespan (Verburgh 2015). The decrease of the IIS pathway in C. elegans by 279 
Kimura and colleagues was one of the first experiments to show an increase in lifespan 280 
relating to diminished insulin signaling (Kimura et al. 1997). This was confirmed by several 281 
other studies, with Blüher and colleagues showing that the knock-out of a fat specific insulin 282 
receptor resulted in an increase in lifespan of 18% (Blüher, Kahn, and Kahn 2003) and 283 
Taguchi et al finding that the knock-out of downstream substrates of the IIS pathway caused 284 
a 32% increase in female mice lifespan (Taguchi, Wartschow, and White 2007). Furthermore, 285 
serum IGF-1 levels in 31 different mouse strains negatively correlated to average lifespan 286 
(Yuan et al. 2009). Some encouraging evidence has also been found relating IIS to human 287 
longevity; IIS related polymorphisms correlate to lifespan (Bonafè et al. 2003; Kojima et al.) 288 
and several centenarians were found to have loss of function mutations in the IGF-1 receptors 289 
(Suh et al. 2008). Conversely, people affected by acromegaly, characterized by increased GH 290 
release, experienced a 2-3 fold increase in death rate (Suh et al. 2008; Clayton 2003; 291 
Verburgh 2015). More recently, reduced growth hormone secretion, and thus indirectly IIS 292 
activity, was shown to correlate with human familial longevity (van der Spoel et al. 2016) 293 
and genomewide meta-analysis studies linked several gene loci to longevity and to levels of 294 
circulating IGF-related proteins (Teumer et al. 2016).  These studies show that this pathway 295 
and its role in lifespan is conserved in more complex organisms.  296 
 297 
Several rodent studies have suggested insulin and IGF may link nutrition to organism 298 
longevity through key functions in tissue-specific stem cell maintenance. Mechanisms such 299 
as autophagy, compromised by IIS overstimulation, carry out key functions within the stem 300 
cell population.  FoxO3A was proven essential for efficient clearing of age-related cellular 301 
debris which is known to prevent malfunctioning of stem cells and to lead to improved 302 
longevity (Warr et al. 2013; Cuervo 2008). The IIS pathway also appears to have important 303 
functions on the regulation of neural stem cells specifically, with studies implicating it in 304 
both development and adulthood. 305 
IGF-1 overexpression alone and IGF-1 and insulin overexpression on embryonic NSC for 306 
example, highlighted that insulin pushes towards increased differentiation while IGF-1 307 
pushes towards a proliferative phenotype (Arsenijevic et al. 2001). Furthermore, studies have 308 
shown that overexpression of IGF-1 leads to increased brain size due to increased 309 
myelination (Carson et al. 1993). Finally, Igf-1 null mice presented with decreased 310 
proliferation and differentiation of oligodendrocyte lineage (Ye et al. 2002).  311 
 312 
Whether these effects persist into adulthood requires further investigation. Recently however, 313 
Chaker and colleagues showed that the inhibition of IGF-1 signaling in rodent adult olfactory 314 
bulb NSCs was able to hinder age-related stem cell decline and preserve the production and 315 
integration of newborn neurons (Chaker et al. 2015). IGF-1 was also shown to stimulate 316 
proliferation of adult hippocampal NSC both in vivo and in vitro while blocking the 317 
PI3K/Akt pathway stopped the proliferative effects of IGF-1 on NSCs (Åberg et al. 2003; 318 
Aberg et al. 2000). This was later supported by  Chigogora and colleagues finding a 319 
correlation between IGF-1 levels and an elevated risk of human depression (Chigogora et al., 320 
n.d.), a disorder known to involve neurogenic and possible NSC deregulation (Hill, Sahay, 321 
and Hen 2015). Furthermore, the deletion of the FoxO family members results in increased 322 
brain size and proliferation during development but also in a depletion of the progenitor pool 323 
and ultimately a decrease of SVZ adult neurogenesis (Paik et al. 2009; Renault et al. 2009). 324 
FoxO3 in particular seems to regulate quiescence of the adult SGL and SVZ NSC population 325 
and to have a role in oligodendrocyte regulation. FoxO transcription factors are also sensitive 326 
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to oxygen changes making them ideal effectors between oxidative stress, a known aspect of 327 
aging, and stem cell maintenance (Renault et al. 2009). Besides these studies, several others 328 
have reported pro-neurogenic effects of insulin when investigating the mTOR pathway as 329 
discussed in section 3.1.  330 
 331 
Interestingly, IGF-II is produced by choroid plexus and released in the cerebrospinal fluid 332 
(CSF), allowing it to come in contact with the neurogenic niches. NSCs in the SVZ extend a 333 
process through the ventricular wall and come in contact with the CSF directly, thereby 334 
allowing its composition to directly alter their regulation. Increased presence of CSF IGF-II 335 
during development for example, promotes neurogenesis (Lehtinen et al. 2011; Ziegler, 336 
Levison, and Wood 2015). IGF-II is also involved in hippocampal neurogenesis in adulthood 337 
(Bracko et al. 2012). In vitro and vivo studies showed IGF-II involvement in promoting NSC 338 
maintenance (Ziegler et al. 2012). Studies have also linked IGF-II dependent mechanisms to 339 
hippocampal-dependent memory retention (D. Y. Chen et al. 2011) and more specifically to 340 
age-related cognitive decline (Steinmetz et al. 2016) in rodents, further supporting a link 341 
between IGF-II and NSCs function and  presenting a key target for further researching 342 
seeking to preserve AHN during aging (See Table 1).  343 
 344 
The overall effects of this pathway on NSC regulation however, remain inconclusive due to a 345 
limited number of concordant studies (Åberg et al. 2003; Itoh et al. 2012); some studies have 346 
reported increased IIS resulting in a beneficial increase in adult neurogenesis, for example 347 
during GH and IGF-1 mediated increases in neurogenesis as a result of exercise (Berg and 348 
Bang 2004) or following a blueberry supplemented diet in rodents (Shukitt-Hale et al. 2015). 349 
In contrast, CR, which is known to directly target and diminish IIS, has also been proven 350 
beneficial for both cognition and longevity in rodent models of Alzheimer’s disease (Parrella 351 
et al. 2013). Figure 2 summarizes some of the NSC functions affected by the IIS pathway. As 352 
for mTOR, this highlights the need of a fine-tuned balance between IIS activation and 353 
inhibition throughout the lifespan. It is likely that several other factors such as oxidative state 354 
of the cell, biological age and brain region all play a role in this balance and can propel 355 
towards a positive or negative effect of the IIS pathway. 356 
3.3. Sirtuins 357 
Sirtuins are a group of deacetylases initially shown to extend lifespan in yeast by regulating 358 
mitochondrial function and cellular redox state (Aguilaniu et al. 2003). Deacetylases are key 359 
regulatory proteins as they can control the expression of several genes. Furthermore, sirtuin 360 
activity is NAD-dependent, making them likely candidates for the molecular link between 361 
metabolism and aging owing to their ability to respond to the cell’s energy status. Indeed, 362 
Sir2 activation in yeasts mimics CR-induced longevity, which in turn was shown to depend 363 
on the Sirtuin pathway (Lin, Defossez, and Guarente 2000). Increased lifespan as a result of 364 
sirtuin overexpression was also confirmed in other organisms such as Drosophila and C. 365 
elegans (L Guarente 2007). Similarly, the mammalian components of the sirtuin family, 366 
SIRT1 and SIRT4 have also been implicated in CR diet-regulated processes, showing that the 367 
link between metabolism and aging could be conserved across species (L Guarente 2007). 368 
Research into Sirtuins also highlighted the importance of NAMPT, the rate limiting enzyme 369 
in mammalian NAD+ synthesis; aging is accompanied by chronic DNA damage which leads 370 
to NAD+ depletion, Sirt1 inactivation and thus mitochondrial dysfunction (Leonard Guarente 371 
2014). Overexpression of NAMPT can rescue NAD+ levels and counteract these changes as 372 
shown by interesting studies investigating its effects on the accelerated aging disorder, 373 
Cockanye syndrome (van der Veer et al. 2007; Leonard Guarente 2014; Scheibye-Knudsen et 374 
al. 2014). The importance of NAD+ and sirtuins in aging was also supported by recent 375 
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studies by Song and colleagues showing that NAMPT inhibition is sufficient to induce 376 
senescence in human fibroblasts(Song et al. 2015).  377 
 378 
The above studies however did not focus on the effects of NAMPT on NSCs. Interestingly, a 379 
recent study showed that NAMPT ablation recapitulated aspects of NSC aging such as 380 
decreased NSC proliferation in rodents (Stein and Imai 2014), suggesting that NAMPT and 381 
the sirtuin pathway play key roles in NSC aging as well. Studies are now beginning to 382 
integrate the role of sirtuins, aging and diet or nutrition on the CNS specifically. For example, 383 
increased Sirt1 levels in murine brains due to CR were shown to increase anxiety and 384 
decrease exploratory drive (Libert et al. 2011). Whilst NSC function was not assessed in 385 
these studies, these conditions are known to involve deregulation of hippocampal 386 
neurogenesis (Libert et al. 2011; Hill, Sahay, and Hen 2015) making it a plausible underlying 387 
mechanism. These studies also highlighted a possible disadvantage of increased Sirt1 activity 388 
and CR.  In line with this, when the effect of SIRT1 deletion was investigated in prion 389 
disease, a condition in which neurogenic deregulation is also implicated (Gomez-Nicola et al. 390 
2014), it was found to delay disease onset and to prolong the healthy portion of the affected 391 
animals. This was mimicked by CR (D. Chen et al. 2008). In contrast, others have shown that 392 
sirtuins can have neuroprotective functions in response to neuronal damage and 393 
neurodegenerative conditions; firstly, SIRT1 is upregulated in mouse models of Alzheimer’s 394 
disease and amyotrophic lateral sclerosis and shown to enhance neuronal survival both in 395 
vitro and in vivo (Kim et al. 2007).  Furthermore, SIRT1 was also found responsible for 396 
neuroprotective effects in murine models of axonal injury (Araki, Sasaki, and Milbrandt 397 
2004). SIRT1 overexpression was found to replicate the beneficial effects of CR in the 398 
context of several neurodegenerative conditions in various animal models (Gräff et al. 2013). 399 
 400 
As many neurodegenerative conditions experience changes in neurogenesis, it is likely Sirt1 401 
conveys some of its effects by influencing NSC function. SIRT1 activation in particular was 402 
linked to changes in neurogenesis in the perinatal SVZ; oxidizing conditions were found to 403 
activate SIRT1 and push the progenitor pool towards astrocytic differentiation whereas a 404 
reducing environment would promote neuronal differentiation(Prozorovski et al. 2008). 405 
Similarly, blocking Sirt1 activity disengaged redox changes from SVZ NSC fate(Prozorovski 406 
et al. 2008). Rafalski et al. in contrast, showed that Sirt1 inactivation pushed NSCs towards 407 
an oligodendrocyte lineage. (Rafalski et al. 2013). Following Prozorovski’s results, it is 408 
possible that the neuroprotective effect of SIRT1 activation, in part, is explained by improved 409 
CNS support from an increased number of astrocytes (See Table 1). An interesting avenue 410 
would be to investigate whether this finding is replicated in the DG and how this SIRT1-411 
mediated modulation of the NSC pool changes with age.   412 
 413 
Finally, these findings are now being investigated in human populations, Libert and 414 
colleagues for example showed that rare human SIRT1 variants are associated with anxiety 415 
and mood disorders(Libert et al. 2011). Interestingly, Sirt1 is also one of the two genes 416 
recently implicated in major depressive disorder by whole-genome sequencing findings (Cai 417 
et al. 2015). Though dietary interventions such as CR seem to be the most potent effectors of 418 
Sirtuin activation, some nutrients, like polyphenols have also been identified to directly 419 
activate components of this family (Howitz et al. 2003). Together the studies reported above, 420 
suggest the relationship between Sirt1, CR and aging is regulated by intricate mechanisms, 421 
which become even more complex when acting upon different types of NSCs. The key 422 
NSC’s functions acted upon by the sirtuin pathway are reported in Figure 2. 423 
 424 
 425 
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4. Epigenetics 426 
 427 
Epigenetics is at the forefront of aging research, a position supported by the recent 428 
establishment of an ‘epigenetic clock’ by Steve Horvath, and has clear functions in adapting 429 
the organism’s responses to its environment. These attributes make it a key mechanism 430 
mediating cellular and molecular responses to diet and aging processes. (Rea, Dellet, and 431 
Mills 2015). Epigenetic modulation comprises many mechanisms and is usually identified as 432 
the driving force behind changes in gene expression, which are not due to DNA sequence 433 
mutations. Such a process clearly has very important functions in stem cell regulation of 434 
different tissues as it can confer lineage-determining decisions as well as maintain 435 
quiescence.  Epigenetics also plays an important role in aging; twin studies showed that 436 
genetic background only has a 25% influence on longevity (Herskind et al. 1996) suggesting 437 
that the remaining effects would be dictated by the environment, which usually ensues its 438 
effects through epigenetics. A role for epigenetics is also supported by notion that the effect 439 
of genetic variations on cognition and brain structure increases with age, recently reviewed 440 
by (Papenberg, Lindenberger, and Bäckman 2015). One of such environmental factors able to 441 
cause epigenetic changes is likely to be diet.  442 
 443 
A line of thought believes that as epigenetic changes are less permanent, it would be more 444 
efficient to target and reverse them rather than targeting any genetic mutations which may 445 
arise as a result of aging (Rando and Chang 2012; Beerman and Rossi 2015). By restoring a 446 
“young” epigenetic environment one may be able to reverse age-related deficit; in a similar 447 
manner to the aforementioned heterochronic parabiosis studies (Villeda et al. 2014). Another 448 
factor supporting the notion that targeting epigenetics may be an efficient way to reverse 449 
aging comes from studies showing that only a small number of loci are altered consistently 450 
throughout aging, allowing for targeted interventions rather than global ones (Beerman and 451 
Rossi 2015). Furthermore, epigenetic changes could be used as aging biomarkers, providing 452 
important information on the aging rate of an organism, with the potential to enable more 453 
precise preventive strategies. It is therefore important for us to understand how age and 454 
nutrition affect epigenetics and how this causes alterations in NSC regulation, disease 455 
progression and longevity. For the remainder of this section we will evaluate the evidence for 456 
such a relationship. 457 
 458 
4.1. Epigenetics and nutrition 459 
There are several studies showing perinatal or in utero nutrition can have vast effect on health 460 
later in life, mainly related to cardiovascular disease, diabetes and obesity (Choi and Friso 461 
2010). Interestingly, these effects were also witnessed in the offspring of the affected animals 462 
suggesting that epigenetic changes could be passed through generations. The involvement of 463 
epigenetics was also confirmed via methylome analysis, though a causal link is yet to be 464 
shown (Radford et al. 2014; Fontana and Partridge 2015). Such mechanisms are set in place 465 
to ensure adaptation for the fetus to its environment – CR and DR prepares a fetus to food 466 
scarcity whilst over nutrition primes for a nutrient abundant environment. Studies have 467 
suggested it may be the mismatching of predicted and actual nutrient availability to cause 468 
some of the detrimental health effects later in life (Perera and Herbstman 2011).  469 
 470 
While epigenetic changes occurring during the malleable stages development in response to 471 
nutrition have been extensively studied, those happening during adulthood are less known. 472 
The evidence from developmental studies reported above, however shows that mechanisms 473 
are set in place for epigenetics to respond to dietary and nutritional cues through the lifespan. 474 
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Indeed, diet can alter epigenetics in several ways, these include the donation of methyl 475 
groups and the regulation of several enzymes (Mathers and Ford 2009). As well as the 476 
alterations in response to CR and DR, other dietary alterations can have effects on 477 
epigenetics, such as the intake of specific nutrients. Studies on agouti mice showed a methyl-478 
supplemented diet was able to cause DNA hypermethylation, making it likely for diet-479 
acquired methyl donors like choline and methionine (an essential amino acid) to have similar 480 
effects (Niculescu, Craciunescu, and Zeisel 2006; Waterland and Jirtle 2003; Waterland, 481 
Travisano, and Tahiliani 2007). Furthermore, the trace mineral zinc interacts with histone 482 
deacetylase regulation (HDAC) and causes their inhibition (Myzak, Ho, and Dashwood 2006) 483 
whilst resveratrol, a dietary phenol, activates the HDAC SIRT1 (Rafalski and Brunet 2011). 484 
Vitamin D also appears to form an important link between nutrition, aging and epigenetics as 485 
its varying concentrations can delay the aging phenotype in mice and its mechanism of action 486 
is known to involve histone acetylases (HATs) and HDACs (Tuohimaa 2009).  487 
 488 
4.2. Epigenetics, aging and neural stem cells 489 
Several years ago it was found that cellular methyl content declines with increasing age in 490 
mammals (Wilson and Jones 1983). This loss is likely to contribute to genomic instability, 491 
which is a hallmark of aging cells. Recently, Horvath and colleagues showed the existence of 492 
an epigenetic clock and developed a predictor able to estimate the methylation age of most 493 
tissues or cell types, suggesting that specific epigenetic changes occur as a result of age 494 
(Horvath 2013). 495 
 496 
Though there are a number of possible epigenetic marks, methylation is the mark considered 497 
to be the most stable one and thus the most likely candidate for encoding aging and 498 
nutritional changes. Methylation changes as a result of age can be divided into two main 499 
categories: those resulting from loss of fidelity when copying methylation marks and those 500 
arising from abnormal addition or removal of methylation marks. Further to this, a decrease 501 
in the activity and expression of the DNA methyltransferase DNMT1 was found with 502 
increasing age (Cooney 1993). Interestingly, DNMT1 controls stem cell balance and lineage 503 
decisions in several tissues; its knock out in embryonic NSCs, for example, causes a 504 
preferential push towards astroglial differentiation(Fan et al. 2005). DNMT1 loss in general 505 
causes an aging phenotype highlighting it as a key molecule governing aging processes 506 
(Beerman and Rossi 2015). In contrast, some housekeeping genes that are usually 507 
unmethylated seem to become methylated with age. This may be due to an increase in 508 
DNMT3 activity; DNMT3 is a methyltransferase responsible for de novo methylation, a 509 
process shown to be key in regulating stem cells as it halts self-renewal to allow 510 
differentiation. A DNMT3 knock out in mouse in fact showed impaired post-natal SVZ and 511 
SGL NSC differentiation (Wu et al. 2010) (See Table 1). 512 
 513 
An important methylation mark, studied in the field of aging and NSCs, is the methylation of 514 
lysine 27 on histone 3 (H3K27). The differing methylation of this mark in fact can regulate 515 
adult NSC differentiation; when this mark has a single methylation, transcription is enabled, 516 
when the mark has 2 or 3 methyl groups gene transcription is repressed (Zhang et al. 2014). 517 
Another epigenetic mark often involved in aging is histone acetylation; several histone 518 
acetylases (HATs) are key in regulating the NSC pool by affecting both proliferation and 519 
differentiation of the neural progenitors. Sirtuins as detailed above are part of this family. 520 
There is also evidence of different epigenetic marks influencing one another – i.e. DNA 521 
methylation being restricted by acetylation marks (Beerman and Rossi 2015). See figure 2 for 522 
a representation of this interconnection. Mathers and Ford suggest that changes in 523 
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methylation do not occur in every cell in a tissue. They explain how this leads to promoter 524 
methylation heterogeneity and thus to divergent gene expression and cellular response across 525 
different tissues with increasing age (Mathers and Ford 2009). Together these studies show 526 
that epigenetic mechanisms are pivotal to a permissive or restricting environment for gene 527 
transcription in response to environmental cues and are therefore likely molecular effectors of 528 
nutrient intake and its ensuing effect on NSC regulation.  529 
 530 
Finally, as well as sharing common downstream mechanisms, aging and nutrition can also 531 
affect one another; for example, nutrient intake may change as a result of age which could 532 
then cause the age-related epigenetic changes. A reduction of fruit and vegetable intake for 533 
instance, would reduce the intake of zinc and thus affect HDAC function (Mathers and Ford 534 
2009). Given the prominent role played by NSCs during aging, an exciting avenue would be 535 
to explore epigenetic changes in these cells in response to diet. 536 
5. Conclusion 537 
 538 
In conclusion, though much progress has been made in establishing the role played by 539 
nutrition in longevity, and on stem cells more broadly, its role in NSCs regulation is still to be 540 
elucidated. In this review we have discussed how mTOR / IIS pathway inhibition and sirtuin 541 
activation may enhance longevity and CNS function, an effect achieved at least in part, 542 
through their impact on NSC function. Importantly, we have described how these responses 543 
can be shaped by diet and nutrition. 544 
  545 
Whilst the positive impacts of CR and IF continue to be detailed in model systems, more 546 
targeted pharmacological approaches may be beneficial for use in frail and elderly 547 
populations. This highlights the need for a more thorough understanding of the molecular 548 
pathways involved in these dietary paradigms.   549 
Further to this, much more research into the genetic and epigenetic influences of diet and 550 
nutrition is required, to refine populations that potentially stand to gain the most from such 551 
interventions. Despite these caveats, there is much excitement in the field as dietary 552 
paradigms such as IF are employed in human studies and the ensuing encouraging results 553 
with regards to their impact on cognitive performance. (Fontana and Partridge 2015; 554 
Brandhorst et al. 2015).   555 
  556 
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and Sirtuin pathways in NSCs function. 1015 
NSC- Neural Stem Cells, IIS -Insulin and Insulin-like Signaling, DG- Dentate Gyrus, SVZ- 1016 
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mTOR / IIS Rat 
In 
Vitro 
Embryonic Increased 
insulin levels 
Increase in differentiated 
neurons, which was 
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2003) 
IIS Mouse 
In 
Vitro 
Striatal Increased 
insulin  
Increases NSCs 
differentiation 
(Arsenijevic et 
al. 2001) 
IIS Mouse 
In Vivo 
Perinatal IGF-1 
overexpression 
Increase in number of 
neurons and of 
oligodendrocytes. 
(Carson et al. 
1993) 
IIS Mouse 
In Vivo 
Perinatal IGF-1 KO Decreased proliferation and 
differentiation of 
oligodendrocytes 
(Ye et al. 2002) 
IGF-1 Mouse 
In vivo 
SVZ IGF-1R KO Reduced age related 
depletion of NSC 
(Chaker et al. 
2015) 
IGF-II Mouse 
In 
Vitro 
Perinatal IGF-II 
treatment 
Increased NSC expansion 
and promoted self-renewal  
(Ziegler et al. 
2012) 
IGF-II Mouse 
In 
Vitro 
DG Sh-RNA 
knockdown of 
IGF-II 
Impaired proliferation (Bracko et al. 
2012) 
Sirtuins Mouse 
In 
Vitro 
Perinatal 
SVZ 
Oxidation or 
Sirt1 
activation 
Enhanced astrocytic lineage (Prozorovski et 
al. 2008) 
Sirtuins Mouse 
In 
Vitro 
Perinatal 
SVZ 
Reducing 
environment 
Enhanced neuronal lineage (Prozorovski et 
al. 2008) 
Sirtuins Mouse 
In 
Vitro 
Perinatal 
SVZ 
Sh-RNA 
knockdown of 
Sirt1 
Disengaged neural fate from 
redox conditions 
(Prozorovski et 
al. 2008) 
Sirtuins Mouse 
In Vivo 
SVZ and 
DG  
Inactivation of 
Sirt1 
Increased oligodendrocyte 
differentiation and 
myelination 
(Rafalski et al. 
2013) 
Sirtuins/ 
NAMPT 
Mouse 
In Vivo 
DG Measuring 
/ablating 
NAMPT 
NAMPT levels decrease 
with age, its ablation reduces 
NSC proliferation and 
oligodendrogenesis 
(Stein and Imai 
2014) 
Epigenetics Mouse 
In 
Vitro 
Embryonic Dnmt1 
knockout 
Increased astrocytic 
differentiation 
(Fan et al. 2005) 
Epigenetics Mouse 
In 
Vitro 
Perinatal 
SVZ 
Dnmt3 
knockout 
Impaired neuronal 
differentiation 
(Wu et al. 2010) 
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FIGURE LEGENDS: 1020 
 1021 
Figure 1: Diagram summarizing the proposed relationship between aging, nutrition and 1022 
neural stem cells.  Aging and dietary modulation such as calorie restriction (CR) can alter the 1023 
composition of the systemic environment, which affects epigenetic regulation and several 1024 
nutrient-sensing pathways, including the mTOR, Sirtuin and Insulin and Insulin like signaling 1025 
(IIS) pathways. These in turn alter neural stem cell (NSC) regulation and can predispose to 1026 
disease and cognitive decline. 1027 
 1028 
 1029 
Figure 2:  Schematic summarizing the key effects of the Insulin/ Insulin-like Growth factor 1030 
(IIS) (in purple), mTOR (in green), sirtuin (in blue) and epigenetic (in orange) pathways on 1031 
neural stem cell (NSC) function as a result of diet and aging. Solid arrows represent 1032 
relationships between the molecular pathways (represented by the four rectangles in the 1033 
center) and NSC function (represented by the outer, rounded rectangles) or related 1034 
phenotypes (dotted rounded rectangles) discussed in this review. The dotted arrows connect 1035 
possible molecular mechanisms behind the observed phenotypes reported in this review. Red 1036 
arrows represent an effect caused by the inhibition of the pathway they stem from. Boxes 1037 
with gradient coloring represent functions affected by multiple pathways. 1038 
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